These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6158787)

  • 21. Production of interferon and of plaque enhancing factor by rinderpest-virus.
    el-Zein A; Srour E
    Zentralbl Veterinarmed B; 1985 Jul; 32(6):466-71. PubMed ID: 2413658
    [No Abstract]   [Full Text] [Related]  

  • 22. Altered cellular responses to interferon induction by poly I-poly C: priming and hyporesponsiveness in cells treated with interferon preparations.
    Barmak SL; Vilcek J
    Arch Gesamte Virusforsch; 1973; 43(3):273-83. PubMed ID: 4359178
    [No Abstract]   [Full Text] [Related]  

  • 23. Growth of vesicular stomatitis virus in mosquito cell lines.
    Artsob H; Spence L
    Can J Microbiol; 1974 Mar; 20(3):329-36. PubMed ID: 4132520
    [No Abstract]   [Full Text] [Related]  

  • 24. Cell killing by viruses. II. Cell killing by vesicular stomatitis virus: a requirement for virion-derived transcription.
    Marcus PI; Sekellick MJ
    Virology; 1975 Jan; 63(1):176-90. PubMed ID: 163045
    [No Abstract]   [Full Text] [Related]  

  • 25. Interferon production by individual cells.
    Rodgers R; Merigan TC
    Virology; 1974 Feb; 57(2):467-74. PubMed ID: 4361456
    [No Abstract]   [Full Text] [Related]  

  • 26. Sequential suppression by actinomycin D of interferon production and cellular resistance induced by Poly I:C.
    Vilcek J; Varacalli F
    J Gen Virol; 1971 Oct; 13(1):185-8. PubMed ID: 4331811
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of interferon on human cells releasing oncornaviruses: an assay for human interferon.
    Salzberg S; Heller A; Aboud M; Gurari-Rotman D; Revel M
    Virology; 1979 Feb; 93(1):209-14. PubMed ID: 86229
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-interfering and anti-interferon-inducing properties of adenociral soluble antigens.
    Kovalyova TP; Selivanov AA; Krylov VA; Yurlova TI; Smorodintsev AA
    Acta Virol; 1973 Mar; 17(2):170. PubMed ID: 4144286
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of vesicular stomatitis (visna virus) pseudotypes to demonstrate visna virus receptors in cells from different species.
    Gilden DH; Devlin M; Wroblewska Z
    Arch Virol; 1981; 67(2):181-5. PubMed ID: 6260064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rat interferons. III. Antiviral activity and effect of "priming" on interferon production in homologous and heterologous cell lines.
    Lobodzińska M; Biernacka I; Skurska Z
    Arch Immunol Ther Exp (Warsz); 1975; 23(2):225-31. PubMed ID: 238487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poly(rI) more important than poly(rC) in the interferon induction process by poly(rI)-poly(rC).
    De Clercq E; Stewart WE; De Somer P
    Virology; 1973 Jul; 54(1):278-82. PubMed ID: 4351611
    [No Abstract]   [Full Text] [Related]  

  • 32. Conditional lethal mutants of vesicular stomatitis virus. I. Phenotypic characterization of single and double mutants exhibiting host restriction and temperature sensitivity.
    Simpson RW; Obijeski JF
    Virology; 1974 Feb; 57(2):357-68. PubMed ID: 4361452
    [No Abstract]   [Full Text] [Related]  

  • 33. Enhanced production of interferon by temperature shift-down from 37 C to 25 C in rabbit cell cultures stimulated with Newcastle disease virus.
    Kojima Y; Yoshida F
    Jpn J Microbiol; 1974 May; 18(3):217-22. PubMed ID: 4372433
    [No Abstract]   [Full Text] [Related]  

  • 34. Vesicular stomatitis virus as model system for studies of antisense oligonucleotide translation arrest.
    Robbins I; Lebleu B
    Methods Enzymol; 2000; 313():189-203. PubMed ID: 10595357
    [No Abstract]   [Full Text] [Related]  

  • 35. Interfering and interferon-inducing capacity of NDV. I. Quantitative analysis and physicochemical characteristics.
    Shu HL
    Arch Gesamte Virusforsch; 1974; 46(3-4):179-90. PubMed ID: 4375441
    [No Abstract]   [Full Text] [Related]  

  • 36. Characterization of radioactive human fibroblast-derived beta interferon synthesized in vivo.
    Knight E; Hunkapiller MW
    J Interferon Res; 1981 Feb; 1(2):297-303. PubMed ID: 6180060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-mediated inhibition of virion-directed transcription.
    Manders EK; Tilles JG; Huang AS
    Virology; 1972 Aug; 49(2):573-81. PubMed ID: 4115403
    [No Abstract]   [Full Text] [Related]  

  • 38. Antiviral activity of polynucleotides: poly(2'-fluoro-2'-deoxyuridylic acid).
    De Clercq E; Janik B
    Biochim Biophys Acta; 1973 Sep; 324(1):50-6. PubMed ID: 4356544
    [No Abstract]   [Full Text] [Related]  

  • 39. Rescue of vesicular stomatitis virus from interferon-induced resistance by superinfection with vaccinia virus. II. Effect of UV-inactivated vaccinia and metabolic inhibitors.
    Thacore HR; Youngner JS
    Virology; 1973 Dec; 56(2):512-22. PubMed ID: 4357054
    [No Abstract]   [Full Text] [Related]  

  • 40. Pseudotypes of vesicular stomatitis virus determined by exogenous and endogenous avian RNA tumor viruses.
    Love DN; Weiss RA
    Virology; 1974 Jan; 57(1):271-8. PubMed ID: 4362025
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.